Relative leukocyte telomere length and risk of incident ischemic stroke in men: A prospective, nested case-control approach

Rejuvenation Research

Volumn 13, Issue 4, 2010, Pages 411-414

  Zee, Robert Y L ^a   Castonguay, Amy J ^a   Barton, Nathaniel S ^a   Ridker, Paul M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ARTICLE; BRAIN ISCHEMIA; CASE CONTROL STUDY; CHROMOSOME SIZE; CONTROLLED STUDY; FOLLOW UP; GENE DOSAGE; GENETIC RISK; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TELOMERE;

AGED; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; DOUBLE-BLIND METHOD; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PLACEBOS; PROSPECTIVE STUDIES; STROKE; TELOMERE;

EID: 77956097473     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2009.0975     Document Type: Article

References (15)

1. Fuster JJ, Andres V. Telomere biology and cardiovascular disease. Circ Res 2006;99:1167-1180.
2. van der HarstP,van der SteegeG,deBoer RA, Voors AA, Hall AS, Mulder MJ, van Gilst WH, van Veldhuisen DJ. Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. J Am Coll Cardiol 2007;49:1459-1464.
3. Kurz DJ, Kloeckener-Gruissem B, Akhmedov A, Eberli FR, Buhler I, Berger W, Bertel O, Luscher TF. Degenerative aortic valve stenosis, but not coronary disease, is associated with shorter telomere length in the elderly. Arterioscler Thromb Vasc Biol 2006;26:e114-e117.
4. Ogami M, Ikura Y, Ohsawa M, Matsuo T, Kayo S, Yoshimi N, Hai E, Shirai N, Ehara S, Komatsu R, Naruko T, Ueda M. Telomere shortening in human coronary artery diseases. Arterioscler Thromb Vasc Biol 2004;24:546-550.
5. Brouilette SW, Moore JS, McMahon AD, Thompson JR, Ford I, Shepherd J, Packard CJ, Samani NJ. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: A nested case-control study. Lancet 2007;369:107-114.
6. Brouilette S, Singh RK, Thompson JR, Goodall AH, Samani NJ. White cell telomere length and risk of premature myo-cardial infarction. Arterioscler Thromb Vasc Biol 2003;23: 842-846.
7. Physician's health study: aspirin and primary prevention of coronary heart disease. N Engl J Med 1989;321:1825-1828.
8. Zee RY, Michaud SE, Germer S, Ridker PM. Association of shorter mean telomere length with risk of incident myocar-dial infarction: A prospective, nested case-control approach. Clin Chim Acta 2009;403:139-141.
9. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002;30:e47.
10. Nordfjall K, Eliasson M, Stegmayr B, Melander O, Nilsson P, Roos G. Telomere length is associated with obesity parameters but with a gender difference. Obesity (Silver Spring) 2008;16:2682-2689.
11. Harley CB. Telomerase therapeutics for degenerative diseases. Curr Mol Med 2005;5:205-211.
12. Zhang P, Dilley C, Mattson MP. DNA damage responses in neural cells: Focus on the telomere. Neuroscience 2007;145: 1439-1448.
13. Martin-Ruiz C, Dickinson HO, Keys B, Rowan E, Kenny RA, Von Zglinicki T. Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann Neurol 2006; 60:174-180.
14. Von Zglinicki T, Serra V, Lorenz M, Saretzki G, Lenzen-Grossimlighaus R, Gessner R, Risch A, Steinhagen-Thiessen E. Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and a possible risk factor? Lab Invest 2000;80:1739-1747.
15. Fitzpatrick AL, Kronmal RA, Gardner JP, Psaty BM, Jenny NS, Tracy RP, Walston J, Kimura M, Aviv A. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol 2007;165:14-21.